线粒体基因表达是血小板功能和血液凝结所必需的
Tara R Richman1, Judith A Ermer2, Jessica Baker1
1Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA 6009, Australia; ARC Centre of Excellence in Synthetic Biology, QEII Medical Centre, Nedlands, WA 6009, Australia; Centre for Medical Research, The University of Western Australia, QEII Medical Centre, Nedlands, WA 6009, Australia; Telethon Kids Institute, Northern Entrance, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, WA, Australia.
Cell reports
|October 27, 2023
概括
线粒体基因表达对血小板功能和血液凝结至关重要. 破坏关键基因 (ELAC2,PTCD1,MTIF3) 损害了血小板激活,导致出血障碍.
科学领域:
- 血液学 血液学 血液学
- 线粒体生物学 线粒体生物学
- 分子遗传学 分子遗传学
背景情况:
- 血小板是无核血细胞,对血液静止至关重要.
- 线粒体拥有自己的基因表达机制,但其与核的独立性尚未完全理解.
- 核编码因子对于线粒体的氧化酸化和血小板中的能量产生至关重要.
研究的目的:
- 研究特定线粒体基因表达因子 (ELAC2,PTCD1,MTIF3) 在无核血小板中的作用.
- 阐明线粒体基因表达自主性在血小板功能中的重要性.
- 了解线粒体基因表达受损对血液静止和血栓形成的影响.
主要方法:
- 在小鼠血小板中条件删除Elac2,Ptcd1和Mtif3基因.
- 分析巨核细胞流动性,血小板计数和网状血小板水平.
- 评估出血时间和血小板激活.
- 转录和蛋白质组分析以评估分子变化.
主要成果:
- 删除ELAC2,PTCD1或MTIF3导致巨核细胞化增加和循环网状血小板的增加.
- 这些因素的丧失导致了血小板缩和长时间的出血时间.
- 缺陷的线粒体基因表达显著降低了主激素诱导的血小板激活.
- 研究人员发现,线粒体基因表达对纤维素分解,血液静止和血液凝固至关重要.
结论:
- 由ELAC2,PTCD1和MTIF3调节的线粒体基因表达对血小板生物发生和功能至关重要.
- 血小板中线粒体基因表达通路的破坏对血液静止和出血有深远的影响.
- 血小板是研究无核细胞中线粒体基因表达自主性的宝贵模型.
相关概念视频
01:18Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
01:22Formation of the Platelet Plug
6.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
537
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
537
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K
01:28Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K